Skip to content
Search

Latest Stories

Pharmacist receives Dr. Falk/Guts UK Awards 2024 for transforming Autoimmune Hepatitis care

Pharmacist receives Dr. Falk/Guts UK Awards 2024 for transforming Autoimmune Hepatitis care
Pharmacist, Sonal Patel, has won Dr. Falk/Guts UK Awards 2024 for revolutionizing the management of autoimmune hepatitis with her innovative patient care approach

In a notable accolade for outstanding contributions to healthcare, a Specialist Hepatology pharmacist, Sonal Patel, has been awarded the Dr. Falk/Guts UK Award 2024 for the Pharmacist Recognition prize winner category.

Patel, who works at the Guy's and St Thomas' Hospital, received the award for her ground-breaking work in improving the management of autoimmune hepatitis (AIH) and was presented with her award by BSG Chair Prof Andy Veitch & Dr Riadh Jazrawi, Medical Director, Dr Falk Pharma UK, at an event  during the British Society Gastroenterology annual meeting in Birmingham recently.


Autoimmune Hepatitis (AIH) is a chronic liver disease characterized by the immune system mistakenly attacking the liver cells, leading to inflammation and potential liver damage.

Patel worked on the establishment of a dedicated specialised pathway to optimise the management of patients diagnosed and treated for autoimmune hepatitis (AIH).

The project highlighted her innovative approach to patient care, which has significantly enhanced treatment outcomes for individuals suffering from AIH.

According to her, prior to the intervention, the management of AIH relied heavily on hepatology consultant clinics, leading to long waiting times and inconsistent patient support.

To address these challenges, Patel collaborated with her team to "redesign our treatment and monitoring pathway for patients with autoimmune hepatitis".

This initiative led to the creation of pharmacist-led immunosuppressant monitoring clinics, integrated into existing pharmacy services at the hospital.

"The management of autoimmune hepatitis(AIH) encompasses the use of steroids and long-term immunosuppression to control hepatic inflammation," Patel explained.

"Close monitoring and careful titration of these medicines are required to strike a balance between achieving therapeutic benefit whilst minimising the risk of adverse effects."

Patel’s approach also included the development of patient information leaflets, an email helpline for direct communication, and both virtual and face-to-face consultations.

This multifaceted strategy has enabled a more responsive and flexible patient care model, including home medication delivery and shared care protocols.

pharmacist; Image Credit: Dr Falk/Guts Awards 2024

"I felt it was important to make pharmacist-led services central to this pathway. By focusing on optimising medication safety, efficacy and adherence, this was an opportunity to showcase our skillset and strengths, and a pertinent example of how pharmacists can directly support the wider multidisciplinary team (MDT) with patient care," said Patel.

"It has been rewarding to see the impact of the pharmacy service on our patients. Several patients previously lost to follow up have since re-engaged with our services, and we have received positive feedback through patient experience forums."

Dr. Sreelakshmi Kotha, Consultant Hepatologist at Guy’s and St Thomas’, praised Patel’s efforts, stating, "Sonal has been actively involved in setting up and running the

pharmacist autoimmune hepatitis clinic at the GSTT alongside hepatology consultants.

"These weekly clinics significantly improved the quality of care provided to autoimmune hepatitis patients and reduced the pressures on consultant clinics.

In particular the clinics have supported us to manage the cohort of patients who struggle with compliance to medications.

"It would be much more difficult to run the autoimmune hepatitis service without the availability of the pharmacy clinic."

Expressing her gratitude, Patel said, “This award is a wonderful recognition of the impact pharmacists can have on patient outcomes.

"It underscores the essential role we play as part of the multi-disciplinary team and highlights the value of pharmacist-led services."

Dr. Falk/Guts UK Awards are renowned for honouring exceptional contributions to the fields of gastroenterology and hepatology.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less